TCDD-induced CYP1A1 expression, an index of dioxin toxicity, is suppressed by flavonoids permeating the human intestinal Caco-2 cell monolayers

Journal of Agricultural and Food Chemistry

Volumn 54, Issue 23, 2006, Pages 8891-8898

  Hamada, Mika ^a   Satsu, Hideo ^a   Natsume, Yayoi ^a   Nishiumi, Shin ^b   Fukuda, Itsuko ^b   Ashida, Hitoshi ^b   Shimizu, Makoto ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

Aryl hydrocarbon receptor; Caco 2; CYP1A1; Flavonoid; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CYTOCHROME P450 1A1; FLAVONOID;

ARTICLE; BIOSYNTHESIS; CELL STRAIN CACO 2; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CACO-2 CELLS; CYTOCHROME P-450 CYP1A1; DRUG INTERACTIONS; ENZYME INDUCTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLAVONOIDS; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRACHLORODIBENZODIOXIN;

EID: 33751261911     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf060944t     Document Type: Article

References (40)

1. Landers, J. P. Ah receptor and the mechanism of dioxin toxicity. Biochem. J. 1991, 276, 273-287.
2. Safe, S. Molecular biology of the Ah receptor and its role in carcinogenesis. Toxicol. Lett. 2001, 120, 1-7.
3. Sweeney, M. H.; Mocarelli, P. Human health effect after exposure to 2,3,7,8-TCDD. Food Addit. Contam. 2000, 17, 303-316.
4. Sogawa, K.; Fujii-Kuriyama, Y. Ah receptor, a novel ligand-activated transcription factor. J. Biochem. (Tokyo) 1997, 122, 1075-1079.
5. Hahn, M. E. The aryl hydrocarbon receptor: A comparative perspective. Comp. Biochem. Physiol., C 1997, 121, 23-53.
6. Bunger, M. K.; Moran, S. M.; Glover, E.; Thomae, T. L.; Lahvis, G. P.; Lin, B. C.; Bradfield, C. A. Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying a mutation in the nuclear localization sequence of the aryl hydrocarbon receptor. J. Biol. Chem. 2003, 278, 17767-17774.
7. Mayer, B. K.; Perdew, G. H. Characterization of the AhR-hsp90-XAP2 core complex and the role of the immunophilin-related protein XAP2 in AhR stabilization. Biochemistry 1999, 38, 8907-8917.
8. Kazlauskas, A.; Poellinger, L.; Pongraz, I. Evidence that the cochaperone p23 regulates ligand responsiveness of the dioxin (aryl hydrocarbon) receptor. J. Biol. Chem. 1999, 274, 13519-13524.
9. Ko, H. P.; Okino, S. T.; Ma, Q.; Whitlock, J. P., Jr. Dioxin-induced CYP1A1 transcription in vivo: the aromatic hydrocarbon receptor mediates transcription, enhancer-promoter communication, and changes in chromatin structure. Mol. Cell. Biol. 1996, 16, 430-436.
10. Nebert, D. W.; Roe, A. L.; Dieter, M. Z.; Solis, W. A.; Yang, Y.; Dalton, T. P. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in oxidative stress response, cell cycle control, and apotosis. Biochem. Pharmacol. 2000, 59, 65-85.
11. Travis, C. C.; Hatter-Frey, H. A. Human exposure to dioxin. Sci. Total Environ. 1991, 104, 97-127.
12. Djien Liem, A. K.; Furst, P.; Rappe, C. Exposure of populations to dioxins and related compounds. Food Addit. Contam. 2000, 17, 241-260.
13. Ashida, H.; Fukuda, I.; Yamashita, T.; Kanazawa, K. Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin. FEBS Lett. 2000, 476, 213-217.
14. Fukuda, I.; Nishiumi, S.; Yabuchita, Y.; Mukai, R.; Kodoi, R.; Hashizume, K.; Mizuno, M.; Hatanaka, Y.; Ashida, H. A new southwestern chemistry-based ELISA for detection of aryl hydrocarbon receptor transformation: application to the screening of its receptor agonists and antagonists. J. Immunol. Methods 2004, 287, 187-201.
15. Zhai, S.; Dai, R.; Friedman, F. K.; Vestal, R. E. Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids. Drug Metab. Dispos. 1998, 26, 989-992.
16. Ciolino, H. P.; Daschner, P. J.; Yen, G. C. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem. J. 1999, 340, 715-722.
17. Postlind, H.; Vu, T. P.; Tukey, R. H.; Quattrochi, L. C. Response of human CYP1-luciferase plasmids to 2,3,7,8-tetrachlorodibenzo-p-dioxin and polycyclic aromatic hydrocarbons. Toxicol. Appl. Pharmacol. 1993, 118, 255-262.
18. Natsume, Y.; Satsu, H.; Kitamura, K.; Okamoto, N.; Shimizu, M.; Assessment system for dioxin absorption in the small intestine and prevention of its absorption by food factors. Biofactors 2004, 21 (1-4), 375-377.
19. Poland, A.; Knutson, J. C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Ann. Rev. Pharmacol. Toxicol. 1982, 22, 517-554.
20. Morita, K.; Ogata, M.; Hasegawa, T. Chlorophyll derived from Chlorella inhibits dioxin absorption from the gastrointestinal tract and accelerates dioxin excretion in rats. Environ. Health Perspect. 2001, 109 (3), 289-294.
21. Aozawa, O.; Ohta, S.; Nakano, T.; Miyata, H.; Nomura, T. Enhancement of fecal excretion of dioxin isomer in mice by several dietary fibers. Chemosphere 2001, 45, 195-200.
22. Natsume, Y.; Satsu, H.; Hatsugai, A.; Watanabe, H.; Sato, R.; Ashida, H.; Tukey, R. H.; Shimizu, M. Evaluation of intestinal dioxin permeability by using human intestinal Caco-2 cell monolayers. Food. Sci. Technol. Res. 2003, 9 (4), 364-366.
23. Whitlock, J. P., Jr. Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Ann. Rev. Pharmacol. 1990, 30, 251-277.
24. Sun, D.; Lennernas, H.; Welage, L. S.; Barnett, J. L.; Landowski, C. P.; Foster, D.; Fleisher, D.; Lee, K.; Amidon, G. L. Comparison of human duodenum and Caco-2 gene expression profiles for 12 000 gene sequence tags and correlation with permeability of 26 drugs. Pharm. Res. 2002, 19, 1400-1416.
25. Galijatovic, A.; Otake, Y.; Walle, U. K.; Walle, T. Extensive metabolism of the flavonoid chrysin by human Caco-2 and HepG2 cells. Xenobiotica 1999, 29, 1241-1256.
26. Zhang, L.; Zheng, Y.; Chow, M. S. S.; Zuo, Z. Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model. Int. J. Pharm. 2004, 287, 1-12.
27. Kostelac, D.; Rechkemmer, G.; Briviba, K. Phytoestrogens modulate response of estrogen receptors α and β to the estrogen response element. J. Agric. Food. Chem. 2003, 51, 7632-7635.
28. Bank, P. A.; Yao, E. F.; Phelps, C. L.; Harper, P. A.; Denison, M. S. Species-specific binding of transformed Ah receptor to a dioxin responsive transcriptional enhancer. Eur. J. Pharmacol. 1992, 228, 85-94.
29. Ema, M.; Ohe, N.; Suzuki, M.; Mimura, J.; Sogawa, K.; Ikawa, S.; Fujii-Kuriyama, Y. Dioxin binding activities of polymorphic forms of mouse and human arylhydrocarbon receptors. J. Biol. Chem. 1994, 269, 27337-27343.
30. Sanderson, J. T.; Bellward, G. D. Hepatic microsomal ethoxyresorufin O-deethylase-inducing potency in ovo and cytosolic Ah receptor binding affinity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: comparison of four avian species. Toxicol. Appl. Pharmacol. 1995, 132, 131-145.
31. Garrison, P. M.; Tullis, K.; Aarts, J. M.; Brouwer, A.; Giesy, J. P.; Denison, M. S. Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals. Fundam. Appl. Toxicol. 1996, 30, 194-203.
32. Zhou, J.; Henry, E. C.; Palermo, C. M.; Dertinger, S. D.; Gasiewicz, T. A. Species-specific transcriptional activity of synthetic flavonoids in guinea pig and mouse cells as a result of differential activation of the aryl hydrocarbon receptor to interact with dioxin-responsive elements. Mol. Pharmacol. 2003, 63, 915-924.
33. Schrenk, D. Impact of dioxin-type induction of drug-metabolizing enzymes on the metabolism of endo- and xenobiotics. Biochem. Pharmacol. 1998, 55, 1155-1162.
34. Münzel, P. A.; Lehmköster, T.; Brück, M.; Ritter, J. K.; Bock, K. W. Aryl hydrocarbon receptor-induced or constitutive expression of human UDP glucuronosyltransferase UGT1A6. Arch. Biochem. Biophys. 1998, 350, 72-78.
35. Münzel, P. A.; Schmohl, S.; Heel, H.; Kälberer, K.; Bock-Hennig, B. S.; Bock, K. W. Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-butylhydroquinone and 2,3,7,8- tetrachlorodibenzo-p-dioxin in Caco-2 cells. Drug. Metab. Dispos. 1999, 27, 569-573.
36. Rushmore, T. H.; King, A. N. T. Pharmacogenomics, regulation, and signaling pathways of phase I and II drug metabolizing enzymes. Curr. Drug Metab. 2002, 3, 481-490.
37. Galijatovic, A.; Walle, U. K.; Walle, T. Induction of UDP-glucuronosyl-transferase by the flavonoids chrysin and quercetin in Caco-2 cells. Pharm. Res. 2000, 17, 21-25.
38. Sugatani, J.; Yamakawa, K.; Tonda, E.; Nishitani, S.; Yoshinari, K.; Degawa, M.; Abe, I.; Noguchi, H.; Miwa, M. The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics. Biochem. Pharmacol. 2004, 67, 989-1000.
39. Nazarenko, D. A.; Dertinger, S. D.; Gasiewicz, T. A. In vivo antagonism of AhR-mediated gene induction by 3′-methoxy-4′-nitroflavone in TCDD-responsive lacZ mice. Toxicol. Sci. 2001, 61, 256-264.
40. Guo, M.; Joiakim, A.; Reiners, J. J., Jr. Suppression of 2,3,7,8,-tetrachlorodibenzo-p-dioxin (TCDD)-mediated aryl hydrocarbon receptor transformation and CYP1A1 induction by the phosphatidylinositol 3-kinase inhibitor 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Biochem. Pharmacol. 2000, 60, 635-642.